Mosaic HIV-1 vaccination induces anti-viral CD8+ T cell functionality in the phase 1/2a clinical trial APPROACH
J van Duijn, D Stieh, N Fernandez, D King… - Journal of …, 2023 - Am Soc Microbiol
The ability of vaccine-induced T cells to inhibit viral replication may contribute to protect
against human immunodeficiency virus (HIV) acquisition. Here, we tested ex vivo viral …
against human immunodeficiency virus (HIV) acquisition. Here, we tested ex vivo viral …
Mosaic HIV-1 vaccination induces anti-viral CD8+ T cell functionality in the phase 1/2a clinical trial APPROACH
J van Duijn, D Stieh, N Fernandez, D King… - Journal of … - pubmed.ncbi.nlm.nih.gov
The ability of vaccine-induced T cells to inhibit viral replication may contribute to protect
against human immunodeficiency virus (HIV) acquisition. Here, we tested ex vivo viral …
against human immunodeficiency virus (HIV) acquisition. Here, we tested ex vivo viral …
[PDF][PDF] Mosaic HIV-1 vaccination induces anti-viral CD8+ T cell functionality in the phase 1/2a clinical trial APPROACH
J van Duijn, D Stieh, N Fernandez, D King, J Gilmour… - 2023 - researchgate.net
The ability of vaccine-induced T cells to inhibit viral replication may contribute to protect
against human immunodeficiency virus (HIV) acquisition. Here, we tested ex vivo viral …
against human immunodeficiency virus (HIV) acquisition. Here, we tested ex vivo viral …
[HTML][HTML] Mosaic HIV-1 vaccination induces anti-viral CD8+ T cell functionality in the phase 1/2a clinical trial APPROACH
J van Duijn, D Stieh, N Fernandez, D King… - Journal of …, 2023 - ncbi.nlm.nih.gov
The ability of vaccine-induced T cells to inhibit viral replication may contribute to protect
against human immunodeficiency virus (HIV) acquisition. Here, we tested ex vivo viral …
against human immunodeficiency virus (HIV) acquisition. Here, we tested ex vivo viral …
Mosaic HIV-1 vaccination induces anti-viral CD8+ T cell functionality in the phase 1/2a clinical trial APPROACH.
J van Duijn, D Stieh, N Fernandez, D King… - Journal of …, 2023 - europepmc.org
The ability of vaccine-induced T cells to inhibit viral replication may contribute to protect
against human immunodeficiency virus (HIV) acquisition. Here, we tested ex vivo viral …
against human immunodeficiency virus (HIV) acquisition. Here, we tested ex vivo viral …
Mosaic HIV-1 vaccination induces anti-viral CD8+ T cell functionality in the phase 1/2a clinical trial APPROACH.
J van Duijn, D Stieh, N Fernandez, D King… - Journal of …, 2023 - europepmc.org
The ability of vaccine-induced T cells to inhibit viral replication may contribute to protect
against human immunodeficiency virus (HIV) acquisition. Here, we tested ex vivo viral …
against human immunodeficiency virus (HIV) acquisition. Here, we tested ex vivo viral …